Abstract
The fulminant viral myocarditis is associated to a high risk of mortality and heart transplantation in children. Anti-inflammatories and intravenous gamma globulin are used in the majority of studies but the outcome is not always favorable. In this case, we suggest an important role for antiviral therapy in children's fulminant myocarditis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
